OCT 15, 2021 8:27 AM PDT

Anti-seizure properties found in the Cannabinoid CBGA

WRITTEN BY: Kerry Charron

A growing body of research suggests cannabis’s effectiveness in minimizing seizure activity, but a recent study highlights the critical role the specific cannabinoid CBGA might play in treating some of the most debilitating forms of epilepsy. Researchers at The University of Sydney have identified several rare cannabinoids with anti-seizure properties by studying the effects of cannabigerolic acid (CBGA), cannabidivarinic acid (CBDVA), and cannabigerovarinic acid (CBGVA) on seizures induced in mice. They found that CBGA had the most powerful anti-convulsant effects of these three acidic cannabinoids found in raw cannabis.

The University of Sydney researchers will use this data to develop therapeutic cannabis treatments for Dravet Syndrome and other debilitating forms of epilepsy. Dravet Syndrome (previously called severe myoclonic epilepsy of infancy-SMEI) tends to start with a prolonged seizure in the first year of life, and thereafter patients experience constant seizures which hinder their cognitive and motor development. According to lead researcher Dr. Lyndsey Anderson, "...CBGA was more potent than CBD in reducing seizures triggered by a febrile event in a mouse model of Dravet syndrome. ...We also found CBGA to affect many epilepsy-relevant drug targets."

CBGA was especially effective under certain conditions, such as when CBGA was administered with clobazam. Dr. Anderson considers CBGA "the mother of all cannabinoids” because it is a precursor molecule to both CBD and THC.

Some other key findings of this study are critical for future research on cannabinoid therapy for epilepsies. CBD is a more versatile anticonvulsant for preventing a range of seizures, and higher doses of CBGA may have proconvulsant effects on other seizure types. Therefore, CBGA may only be successful with rare seizure disorders like Dravet Syndrome. These points of information show the nuances of researching CBGA effectiveness in epilepsy treatments. Future research will continue to explore the use of CBG use individually or with other cannabinoids to investigate how therapeutic cannabinoids can reduce seizure activity and provide neuroprotection in treatment of specific forms of epilepsy.

 

 

Sources: British Journal of Pharmacology , Cannabis.net, Science Direct Epilepsy Foundation: Dravet Syndrome

About the Author
  • Kerry Charron writes about medical cannabis research. She is a Cannabis Cultivation Technician for Sanctuary Medicinals Florida, and she has participated in advocacy efforts for medical cannabis.
You May Also Like
NOV 16, 2021
Immunology
How a BBQ Lighter Inspired a New Vaccine Technology
NOV 16, 2021
How a BBQ Lighter Inspired a New Vaccine Technology
It’s the size of a pen, weighs as much as two AA batteries, and works without a power source. A new microneedle de ...
NOV 12, 2021
Technology
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
NOV 12, 2021
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
The use of artificial intelligence to diagnose and monitor health conditions is on the rise. At its most basic level, AI ...
NOV 17, 2021
Microbiology
Large Flu Outbreak at the University of Michigan Draws CDC's Attention
NOV 17, 2021
Large Flu Outbreak at the University of Michigan Draws CDC's Attention
Every year, there is a flu outbreak, and the severity can depend on many factors, like what strain is circulating. Last ...
NOV 19, 2021
Technology
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
NOV 19, 2021
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
Atrial fibrillation (AF) is a common heart condition—by 2030, the Centers for Disease Control estimates that nearl ...
NOV 24, 2021
Cannabis Sciences
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
NOV 24, 2021
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
Platinum-based chemotherapies such as oxaliplatin are used to treat gastrointestinal tumors, especially in the advanced ...
NOV 25, 2021
Health & Medicine
If it looks like a cat and meows like a cat, it must be...a robot!
NOV 25, 2021
If it looks like a cat and meows like a cat, it must be...a robot!
Researchers show improved mood, behavior, and cognition in dementia patients who interact with robotic cats
Loading Comments...